Northwest Biotherapeutics, Inc. (NWBO) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Northwest Biotherapeutics, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Investment Score:
31/100
Weak
Valuation Metrics
P/E Ratio
-4.00
Weak
WeakModerateStrong
P/B Ratio
-4.25
Weak
WeakModerateStrong
Earnings Yield
-24.98%
Weak
WeakModerateStrong
Profitability Health
Return on Equity
106.07%
Strong
WeakModerateStrong
Operating Margin
-4812.45%
Weak
WeakModerateStrong
Net Profit Margin
-6062.08%
Weak
WeakModerateStrong
Growth Indicators
Revenue Growth
-28.47%
Weak
WeakModerateStrong
Net Income Growth
-33.83%
Weak
WeakModerateStrong
EPS Growth
-19.30%
Weak
WeakModerateStrong
Efficiency & Liquidity
Current Ratio
0.06
Weak
WeakModerateStrong
Quick Ratio
0.06
Weak
WeakModerateStrong
Asset Turnover
0.05x
Weak
WeakModerateStrong
Inventory Turnover
0.00x
Weak
WeakModerateStrong